Francesca Mazzoni

Francesca Mazzoni

Auto-generated profile, based on publicly available information

Francesca Mazzoni

Department of Biological Sciences, Center for Cancer, Genetic Diseases and Gene Regulation, Fordham University, Bronx, NY 10458, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2006 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
CGClaudia Gargini
Claudia Gargini
Eva Terzibasi TozziniEva Terzibasi Tozzini
Eva Terzibasi Tozzini
FMFrancesca Mazzoni
Francesca Mazzoni
Enrica StrettoiEnrica Strettoi
Enrica Strettoi

1 September 2014 in Experimental Eye Research
Verified
Journal Article
Closed access
FMFrancesca Mazzoni
Francesca Mazzoni
HSHussein Safa
Hussein Safa
Silvia FinnemannSilvia Finnemann
Silvia Finnemann

24 December 2008 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
FMFrancesca Mazzoni
Francesca Mazzoni
ENElena Novelli
Elena Novelli
Enrica StrettoiEnrica Strettoi
Enrica Strettoi
Retinitis pigmentosa (RP), a family of inherited disorders characterized by progressive photoreceptor death, is a leading cause of blindness with no available cure. Despite the genetic heterogeneity underlying the disease, recent data on animal models show that the degeneration of photoreceptors triggers stereotyped remodeling among their postsynaptic partners. In particular, bipolar and horizontal cells might undergo dendritic atrophy and secondary death. The aim of this study was to investigate whether or not concomitant changes also occur in retinal ganglion cells (RGCs), the only retinal projection neurons to the brain and the proposed substrate for various therapeutic approaches for RP. We assessed the retention of morphology, overall architecture, and survival of RGCs in a mouse model of RP at various stages of the disease. To study the morphology of single RGCs, we generated a new mouse line by crossing Thy1-GFP-M mice (Feng et al., 2000), which express GFP (green fluorescent protein) in a small number of heterogeneous RGCs types, and rd10 mutants, a model of autosomal recessive RP, which exhibit a typical rod–cone degeneration (Chang et al., 2002). We show remarkable preservation of RGC structure, survival, and projections to higher visual centers in the time span from 3 to 9 months of life, well beyond the death of photoreceptors. Thus, unlike second-order neurons, RGCs appear as a considerably stable population of cells, potentially constituting a favorable substrate for restoring vision in RP individuals by means of electronic prostheses or direct expression of photosensitive proteins.

1 September 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
KBKenkichi Baba
Kenkichi Baba
NPNikita Pozdeyev
Nikita Pozdeyev
FMFrancesca Mazzoni
Francesca Mazzoni
SCSusana Contreras-Alcantara
Susana Contreras-Alcantara
CLCuimei Liu
Cuimei Liu
GTGianluca Tosini
Gianluca Tosini
A clear demonstration of the role of melatonin and its receptors in specific retinal functions is lacking. The present study investigated the distribution of MT1 receptors within the retina, and the scotopic and photopic electroretinograms (ERG) and retinal morphology in wild-type (WT) and MT1 receptor-deficient mice. MT1 receptor transcripts were localized in photoreceptor cells and in some inner retinal neurons. A diurnal rhythm in the dark-adapted ERG responses was observed in WT mice, with higher a- and b-wave amplitudes at night, but this rhythm was absent in mice lacking MT1 receptors. Injection of melatonin during the day decreased the scotopic response threshold and the amplitude of the a- and b-waves in the WT mice, but not in the MT1 −/− mice. The effects of MT1 receptor deficiency on retinal morphology was investigated at three different ages (3, 12, and 18 months). No differences between MT1 −/− and WT mice were observed at 3 months of age, whereas at 12 months MT1 −/− mice have a significant reduction in the number of photoreceptor nuclei in the outer nuclear layer compared with WT controls. No differences were observed in the number of cells in inner nuclear layer or in ganglion cells at 12 months of age. At 18 months, the loss of photoreceptor nuclei in the outer nuclear layer was further accentuated and the number of ganglion cells was also significantly lower than that of controls. These data demonstrate the functional significance of melatonin and MT1 receptors in the mammalian retina and create the basis for future studies on the therapeutic use of melatonin in retinal degeneration.

7 September 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASAnamika Sengupta
Anamika Sengupta
KBKenkichi Baba
Kenkichi Baba
FMFrancesca Mazzoni
Francesca Mazzoni
NPNikita V. Pozdeyev
Nikita V. Pozdeyev
Enrica StrettoiEnrica Strettoi
Enrica Strettoi
GTGianluca Tosini
Gianluca Tosini
Melatonin modulates many important functions within the eye by interacting with a family of G-protein-coupled receptors that are negatively coupled with adenylate cyclase. In the mouse, Melatonin Receptors type 1 (MT1) mRNAs have been localized to photoreceptors, inner retinal neurons, and ganglion cells, thus suggesting that MT1 receptors may play an important role in retinal physiology. Indeed, we have recently reported that absence of the MT1 receptors has a dramatic effect on the regulation of the daily rhythm in visual processing, and on retinal cell viability during aging. We have also shown that removal of MT1 receptors leads to a small (3–4 mmHg) increase in the level of the intraocular pressure during the night and to a significant loss (25–30%) in the number of cells within the retinal ganglion cell layer during aging. In the present study we investigated the cellular distribution in the C3H/f+/+ mouse retina of MT1 receptors using a newly developed MT1 receptor antibody, and then we determined the role that MT1 signaling plays in the circadian regulation of the mouse electroretinogram, and in the retinal dopaminergic system. Our data indicate that MT1 receptor immunoreactivity is present in many retinal cell types, and in particular, on rod and cone photoreceptors and on intrinsically photosensitive ganglion cells (ipRGCs). MT1 signaling is necessary for the circadian rhythm in the photopic ERG, but not for the circadian rhythm in the retinal dopaminergic system. Finally our data suggest that the circadian regulation of dopamine turnover does not drive the photopic ERG rhythm.

1 July 2017 in Stem Cell Reports
Verified
Journal Article
Open access
RDRichard J. Davis
Richard J. Davis
NANazia M. Alam
Nazia M. Alam
CZCuiping Zhao
Cuiping Zhao
CMClaudia Müller
Claudia Müller
JSJanmeet S. Saini
Janmeet S. Saini
JSJeffrey H. Stern
Jeffrey H. Stern
Age-related macular degeneration (AMD) is a common cause of central visual loss in the elderly. Retinal pigment epithelial (RPE) cell loss occurs early in the course of AMD and RPE cell transplantation holds promise to slow disease progression. We report that subretinal transplantation of RPE stem cell (RPESC)-derived RPE cells (RPESC-RPE) preserved vision in a rat model of RPE cell dysfunction. Importantly, the stage of differentiation that RPESC-RPE acquired prior to transplantation influenced the efficacy of vision rescue. Whereas cells at all stages of differentiation tested rescued photoreceptor layer morphology, an intermediate stage of RPESC-RPE differentiation obtained after 4 weeks of culture was more consistent at vision rescue than progeny that were differentiated for 2 weeks or 8 weeks of culture. Our results indicate that the developmental stage of RPESC-RPE significantly influences the efficacy of RPE cell replacement, which affects the therapeutic application of these cells for AMD.